Michael Kaswan is Chief Financial Officer of Orchestra BioMed Holdings Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Apr 23 | OBIO Orchestra BioMed | Common Stock, par value $0.0001 per share ("Common Stock") | Option exercise | Acquire M | No | No | 0 | 29,029 | 0.00 | 162,574 |
12 Apr 23 | OBIO Orchestra BioMed | Right to Receive Earnout Shares Common Stock | Option exercise | Dispose M | No | No | 0 | 29,029 | 0.00 | 29,029 |
26 Jan 23 | OBIO Orchestra BioMed | Common Stock, par value $0.0001 per share ("Common Stock") | Grant | Acquire A | No | No | 0 | 133,545 | 0.00 | 133,545 |
26 Jan 23 | OBIO Orchestra BioMed | Right to Receive Earnout Shares Common Stock | Grant | Acquire A | No | No | 0 | 58,058 | 0.00 | 58,058 |
26 Jan 23 | OBIO Orchestra BioMed | Nonstatutory Stock Option Common Stock | Grant | Acquire A | No | No | 10 | 192,566 | 1.93 mm | 192,566 |